3B Blackbio Dx Limited

BSE:532067 Stock Report

Market Cap: ₹17.0b

3B Blackbio Dx Past Earnings Performance

Past criteria checks 4/6

3B Blackbio Dx's earnings have been declining at an average annual rate of -5.6%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been declining at an average rate of 6.2% per year. 3B Blackbio Dx's return on equity is 17.4%, and it has net margins of 47.8%.

Key information

-5.6%

Earnings growth rate

-8.5%

EPS growth rate

Chemicals Industry Growth17.7%
Revenue growth rate-6.2%
Return on equity17.4%
Net Margin47.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How 3B Blackbio Dx makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:532067 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24894427750
30 Jun 24793366670
31 Mar 24742321710
31 Dec 23765317680
30 Sep 23735281660
30 Jun 23717249550
31 Mar 23621259540
31 Dec 22701263450
30 Sep 22684253410
30 Jun 22663191380
31 Mar 22875322380
31 Dec 21873443360
30 Sep 211,157580340
30 Jun 212,109891410
31 Mar 212,2961,139470
31 Dec 202,173965420
30 Sep 201,799786430
30 Jun 20778294360
31 Mar 2030577290
31 Dec 1928862290
30 Sep 1927462270
30 Jun 1925554260
31 Mar 1924052260
31 Dec 1823445240
30 Sep 1823538230
30 Jun 1823435220
31 Mar 1823534210
31 Dec 1721229220
30 Sep 1719724210
30 Jun 1718018210
31 Mar 1716411200
31 Dec 161789200
30 Sep 161789200
30 Jun 161735200
31 Mar 161743200
31 Dec 151932332
30 Sep 151803332
30 Jun 151893200
31 Mar 151902190
31 Dec 141601392
30 Sep 141810372
30 Jun 142070200
31 Mar 142204342
31 Dec 132123322

Quality Earnings: 532067 has high quality earnings.

Growing Profit Margin: 532067's current net profit margins (47.8%) are higher than last year (38.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 532067's earnings have declined by 5.6% per year over the past 5 years.

Accelerating Growth: 532067's earnings growth over the past year (52.2%) exceeds its 5-year average (-5.6% per year).

Earnings vs Industry: 532067 earnings growth over the past year (52.2%) exceeded the Chemicals industry 8%.

Return on Equity

High ROE: 532067's Return on Equity (17.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 21:18
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

3B Blackbio Dx Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution